Correlation Between Enfusion and Lytus Technologies

Can any of the company-specific risk be diversified away by investing in both Enfusion and Lytus Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and Lytus Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enfusion and Lytus Technologies Holdings, you can compare the effects of market volatilities on Enfusion and Lytus Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of Lytus Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and Lytus Technologies.

Diversification Opportunities for Enfusion and Lytus Technologies

-0.68

Correlation Coefficient

Enfusion  Lytus Technologies

Excellent diversification

The 3 months correlation between Enfusion and Lytus is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and Lytus Technologies Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lytus Technologies and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with Lytus Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lytus Technologies has no effect on the direction of Enfusion i.e., Enfusion and Lytus Technologies go up and down completely randomly.

Pair Corralation between Enfusion and Lytus Technologies

Given the investment horizon of 90 days Enfusion is expected to generate 0.29 times more return on investment than Lytus Technologies. However, Enfusion is 3.46 times less risky than Lytus Technologies. It trades about 0.11 of its potential returns per unit of risk. Lytus Technologies Holdings is currently generating about -0.05 per unit of risk. If you would invest  830.00  in Enfusion on September 15, 2024 and sell it today you would earn a total of  235.00  from holding Enfusion or generate 28.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Enfusion  vs.  Lytus Technologies Holdings

Enfusion

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal technical and fundamental indicators, Enfusion displayed solid returns over the last few months and may actually be approaching a breakup point.

Lytus Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lytus Technologies Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Enfusion and Lytus Technologies

The main advantage of trading using opposite Enfusion and Lytus Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, Lytus Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lytus Technologies will offset losses from the drop in Lytus Technologies' long position.

The idea behind Enfusion and Lytus Technologies Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..